Since increased TERC expression activates myelopoiesis, precisely through the induction of GCSF among other myeloid genes, this could be a strategy for treating neutropenia, monocytopenia or telomeric diseases, such as DC. The gene discussed is TERC; the disease is Decreased total monocyte count.